OBJECTIVES: We conducted a prospective pharmacokinetic study of oral co-amoxiclav in patients with melioidosis to determine the optimal dosage and dosing interval in this potentially fatal infection. PATIENTS AND METHODS: Serial plasma concentrations were measured after administration of two 1 g tablets of Augmentin (1750 mg of amoxicillin and 250 mg of clavulanate) to 14 adult patients with melioidosis. Monte Carlo simulation was used to predict the concentration of each drug following mult...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Pharmacokinetic and pharmacodynamic assessment of co-amoxiclav in the treatment of melioidosis.
If you are the owner of this record, you can report an update to it here: Report update to this record